REVIEW
Add like
Add dislike
Add to saved papers

[Percutaneous mitral valve balloon valvulotomy: technique, indications and results].

Praxis 1995 January 18
Since its introduction into clinical practice ten years ago, percutaneous mitral balloon valvotomy has developed into a well accepted procedure for patients with tight mitral stenosis. The different techniques with their pros and cons are discussed. The indications for mitral balloon valvotomy are based on a solid clinical and echocardiographic examination. The procedure itself requires technical skill and experience. After the procedure there is often a dramatic decrease of symptoms by an almost doubled mitral valve area to values of 1.8 to 2.0 cm2. The rate of complications is acceptable and compares well with surgical valvotomy. The most feared complications are pericardial tamponade (1%) and the development of severe mitral regurgitation in 10%. Percutaneous mitral balloon valvotomy is therefore a first choice therapy for well selected patients with tight, pliable mitral stenosis.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app